Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CARDana Stenger, Tobias Feuchtinger, Felicitas Rataj et al.|Blood|2020Cited by 191
Abstract A043: Anti-CD19 CAR T-cells with a CRISPR/Cas9-mediated T-cell receptor knockout show high functionality in the absence of alloreactivity in vitroDana Stenger, Tobias Feuchtinger, Tanja A. Stief et al.|Cancer Immunology Research|2019Cited by 0